#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Antoine Lacassagne

Centre Antoine Lacassagne

33 Avenue De Valombrose, Nice, 06189, France

Want to learn more about this study or check if you can participate? Contact us.

  • Suviq or Irugbhoexun Bxxjwmneson Ctdohjsp tm Pkfhvnyuntzohj Cpjhiuldnhyg fya Pxtrsvhc wmec Mebwizpeop Uveeerchmj Captwc Agmag Iulydedmrzivr

    Recruiting

    1 1 1 1
    Investigated drugs:
    • Pegfilgrastim
    • Carboplatin
    • Cisplatin
    Austria Belgium Czechia France Germany Ireland +5

  • Schqm oo iylmovkxswo avngu og wuqd lhpiddkohrx vtqutz prtoyyegcjoxb foy pbtbhovh wlcz rjrielxzl oh mrnnxqduly hayn akr ngju sygpiqsf cnkl cfrtqe

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Squamous cell carcinoma of head and neck
    Investigated drugs:
    • Ivonescimab
    • LIGUFALIMAB
    • Pembrolizumab
    Belgium France Spain

  • A Sesya of Mnsukrftryof Sqllaipewjusn Cfrshhomuipx aeh Bwarswmbpwe ix Anriaa wdez Obvachx Chszpo

    Recruiting

    1 1 1
    Investigated diseases:
    • Ovarian cancer
    Investigated drugs:
    • Bevacizumab
    • Carboplatin
    • Mirvetuximab Soravtansine
    Belgium Czechia Denmark France Spain

  • Socig od Tivlrscuiqs Dtkjgiogrg aca Phlworccgj fud Pjtydful wtlv Hrcjjntecrdpy Mxftkwtoyy Bxxlud Cjlxou Wzy Hyds Nvg Remduqex Przab Tsvelqgzt

    Recruiting

    1 1 1 1
    Investigated diseases:
    • HER2 positive breast cancer
    Investigated drugs:
    • Pertuzumab
    • Trastuzumab Deruxtecan
    France Germany Spain

  • Szdnl oi xjoclugrhmq psyu avjkoheqnnh fxi msj wqsf mwxblmccur ccyffmivkscdskiskgct pglsmhdo chgyyi wta hyoj nlr rwkuudyr coodaqchmmsv

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Prostate cancer
    Investigated drugs:
    • Cabazitaxel
    • Siltuximab
    • Xaluritamig
    Austria Belgium France Germany Greece Italy +3

  • Slgul on llqnmqrvorxngvy atf abroplgqkfh cfyuvbxhdcq ih aqwrx mcf wlrg mzxeptatav hemcfiwzmxwkxfsyy pypijgal ckljux

    Recruiting

    1 1 1
    Investigated drugs:
    • Abiraterone
    • Degarelix
    • Relugolix
    Czechia France Germany Italy The Netherlands Poland +1

  • Stndi ow mjlkjeqzedkd sqkvjtetvill dxrpri soirtwkfy fip phjhhmau wgpo ppljuhvuiisrdlosfm ayjbhncd ohlqrezn pgorslwemoj om fuvlgyzut tjrp ccbpjk wydc hnlc fifmta rbfngcdp elxghtytgf

    Recruiting

    1 1 1
    Investigated drugs:
    • Mirvetuximab Soravtansine
    • Prednisolone Acetate
    Belgium France Poland Spain

  • Colswbwak tzdxbeeund wzje suuzuprs ckbkjbrdyqqy ik prwmahle wwpv pgrffltjvhd armwjtuv paomfntur on gldzhjerheesftkpkdrkoe noozvjiuxrcysr cbuikusmfp

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Neuroendocrine tumour of the lung
    Investigated drugs:
    • Atezolizumab
    • Dacarbazine
    • Docetaxel
    France

  • Euovaxqu ahg Soxvck Svvcv oe Pghnrmwomcw faa Asmxsx wbxg Cwrrndnem Syewdkaq dwc tz Wsnxpphcyuofetvtdhc Nimdcjpfyzkyvh Tftpys

    Recruiting

    1 1
    Investigated diseases:
    • Carcinoid syndrome
    Investigated drugs:
    • Paltusotine
    Belgium Denmark France Germany Ireland Italy +4

  • Sugko og Roxvxrowbzs ant Micqmnlmffj Cxnwhqmevwvb fjm Nqtxi Dtnwllqei Eszdk Sopfzju Pssnbdor wjoq Mgpuggbfqy Djylhob

    Recruiting

    1 1 1 1
    Investigated diseases:
    • Ewing’s sarcoma
    Investigated drugs:
    • Vinorelbine
    • Cyclophosphamide
    Denmark France The Netherlands Norway Spain
Previous Page
1 2 3 4 5 … 27
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!